ATE336501T1 - Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter - Google Patents

Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter

Info

Publication number: ATE336501T1
Authority: AT; Austria
Prior art keywords: chi; inhibitors; conotoxin peptides; amine transporters; peptides
Prior art date: 1998-10-02

Application number

AT99952156T

Other languages

English (en)

Inventor

Richard James Lewis

Paul Francis Alewood

Iain Andrew Sharpe

Original Assignee

Xenome Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-02

Filing date

1999-10-01

Publication date

2006-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3810492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE336501(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-01 Application filed by Xenome Ltd filed Critical Xenome Ltd

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE336501T1 publication Critical patent/ATE336501T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
150000001412 amines Chemical class 0.000 title abstract 2
230000001537 neural effect Effects 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT99952156T 1998-10-02 1999-10-01 Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter ATE336501T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPP6274A AUPP627498A0 (en)	1998-10-02	1998-10-02	Novel peptides - i

Publications (1)

Publication Number	Publication Date
ATE336501T1 true ATE336501T1 (de)	2006-09-15

Family

ID=3810492

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99952156T ATE336501T1 (de)	1998-10-02	1999-10-01	Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter

Country Status (13)

Country	Link
US (4)	US6794361B1 (de)
EP (1)	EP1117682B1 (de)
JP (2)	JP4447783B2 (de)
AT (1)	ATE336501T1 (de)
AU (1)	AUPP627498A0 (de)
CA (1)	CA2344765A1 (de)
CY (1)	CY1110381T1 (de)
DE (1)	DE69932834T2 (de)
DK (1)	DK1117682T3 (de)
ES (1)	ES2268885T3 (de)
NZ (1)	NZ510813A (de)
PT (1)	PT1117682E (de)
WO (1)	WO2000020444A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP627498A0 (en) *	1998-10-02	1998-10-22	University Of Queensland, The	Novel peptides - i
US6767896B1 (en)	1999-01-29	2004-07-27	Cognetix, Inc.	Conotoxin peptides
WO2002060923A2 (en) *	2001-01-29	2002-08-08	Cognetix, Inc.	B-superfamily conotoxins
ATE547424T1 (de) *	2002-12-02	2012-03-15	Xenome Ltd	Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
EP2412719A1 (de)	2002-12-02	2012-02-01	Xenome Ltd	Chi-Conotoxin-Peptide
EP1791857A4 (de) *	2004-09-09	2009-04-08	Univ Singapore	Konformationswechsel in der toxinfaltung und verwendungen dafür
US8188048B2 (en)	2006-06-23	2012-05-29	Xenome Limited	Combination therapy
CN103372198B (zh) *	2012-04-12	2016-04-06	同济大学	用于抑制病毒的多肽抑制剂
JP6731044B2 (ja)	2015-05-22	2020-07-29	クレムソン・ユニバーシティ・リサーチ・ファウンデーション	生物付着の抑止において用いるためのコノトキシンペプチド
EA201890587A1 (ru)	2015-08-27	2018-09-28	Президент Энд Феллоуз Оф Гарвард Колледж	Композиции и способы для лечения боли

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5051403A (en)	1989-11-22	1991-09-24	Neurex Corporation	Method of treating ischemia-related neuronal damage
AU642582B2 (en)	1991-02-25	1993-10-21	Eli Lilly And Company	Treatment of lower urinary tract disorders
SG50624A1 (en) *	1991-12-30	1998-07-20	Neurex Corp	Methods of producing analgesia and enhancing opiate analgesia
EP1086702B1 (de) *	1994-05-09	2005-04-13	BINDER, William J.	Präsynaptische Neurotoxine gegen Migränekopfschmerzen
JP3833248B2 (ja)	1994-11-03	2006-10-11	ノバルティス・アクチエンゲゼルシャフト	簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
WO1996040064A1 (en)	1995-06-07	1996-12-19	Nexstar Pharmaceuticals, Inc.	Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
DK0835126T3 (da)	1995-06-27	2003-07-14	Elan Pharm Inc	Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser
BR9707636A (pt)	1996-02-22	1999-07-27	Neurosearch As	Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo
GB9614902D0 (en)	1996-07-16	1996-09-04	Rhodes John	Sustained release composition
CZ288739B6 (cs)	1996-08-01	2001-08-15	Galena, A. S.	Cyklosporin obsahující léčivé přípravky
WO1998022126A1 (en)	1996-11-18	1998-05-28	University Of Utah Research Foundation	USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
AU7206398A (en)	1997-05-14	1998-12-08	Neurosearch A/S	Piperidine derivatives as neurotransmitter re-uptake inhibitors
AUPP627498A0 (en) *	1998-10-02	1998-10-22	University Of Queensland, The	Novel peptides - i
WO2000044769A1 (en)	1999-01-29	2000-08-03	University Of Utah Research Foundation	Conotoxin peptides
EP2412719A1 (de) *	2002-12-02	2012-02-01	Xenome Ltd	Chi-Conotoxin-Peptide
ATE547424T1 (de) *	2002-12-02	2012-03-15	Xenome Ltd	Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure

1998
- 1998-10-02 AU AUPP6274A patent/AUPP627498A0/en not_active Abandoned
1999
- 1999-10-01 JP JP2000574555A patent/JP4447783B2/ja not_active Expired - Fee Related
- 1999-10-01 AT AT99952156T patent/ATE336501T1/de active
- 1999-10-01 US US09/787,986 patent/US6794361B1/en not_active Expired - Fee Related
- 1999-10-01 DK DK99952156T patent/DK1117682T3/da active
- 1999-10-01 CA CA002344765A patent/CA2344765A1/en not_active Abandoned
- 1999-10-01 EP EP99952156A patent/EP1117682B1/de not_active Expired - Lifetime
- 1999-10-01 WO PCT/AU1999/000844 patent/WO2000020444A1/en not_active Ceased
- 1999-10-01 ES ES99952156T patent/ES2268885T3/es not_active Expired - Lifetime
- 1999-10-01 NZ NZ510813A patent/NZ510813A/en not_active IP Right Cessation
- 1999-10-01 DE DE69932834T patent/DE69932834T2/de not_active Expired - Lifetime
- 1999-10-01 PT PT99952156T patent/PT1117682E/pt unknown
2004
- 2004-08-13 US US10/918,096 patent/US7326682B2/en not_active Expired - Fee Related
2006
- 2006-11-09 CY CY20061101621T patent/CY1110381T1/el unknown
2007
- 2007-11-02 US US11/934,723 patent/US7994128B2/en not_active Expired - Fee Related
2009
- 2009-10-26 JP JP2009245436A patent/JP2010046088A/ja active Pending
2011
- 2011-05-25 US US13/115,711 patent/US20120277166A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE69932834T2 (de)	2007-08-23
US20050054827A1 (en)	2005-03-10
US6794361B1 (en)	2004-09-21
US7326682B2 (en)	2008-02-05
JP4447783B2 (ja)	2010-04-07
WO2000020444A1 (en)	2000-04-13
US20120277166A1 (en)	2012-11-01
EP1117682A1 (de)	2001-07-25
CA2344765A1 (en)	2000-04-13
AUPP627498A0 (en)	1998-10-22
US20090275498A1 (en)	2009-11-05
JP2010046088A (ja)	2010-03-04
ES2268885T3 (es)	2007-03-16
DE69932834D1 (de)	2006-09-28
DK1117682T3 (da)	2006-12-27
JP2002526098A (ja)	2002-08-20
EP1117682B1 (de)	2006-08-16
PT1117682E (pt)	2006-12-29
EP1117682A4 (de)	2001-12-12
NZ510813A (en)	2003-08-29
US7994128B2 (en)	2011-08-09
CY1110381T1 (el)	2015-04-29

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1117682

Country of ref document: EP

Publication	Publication Date	Title
ATE368688T1 (de)	2007-08-15	Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
MXPA04008077A (es)	2005-12-14	Anticuerpos ant-a° y su uso.
DE69932834D1 (de)	2006-09-28	Chi-Conotoxinpeptide als Inhibitoren neuronaler Amintransporter
DE69931482D1 (de)	2006-06-29	Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
WO2002046407A3 (en)	2003-03-13	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
ATE452903T1 (de)	2010-01-15	Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
NZ510812A (en)	2004-02-27	Novel peptides
WO2001081412A3 (en)	2002-07-11	Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
WO2002046406A3 (en)	2003-04-10	Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
WO2002022678A3 (en)	2003-03-06	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002024910A3 (en)	2003-09-25	Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002057310A3 (en)	2003-07-10	Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002024748A3 (en)	2003-01-03	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046217A3 (en)	2004-01-08	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002033086A3 (en)	2003-03-27	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2003070882A3 (en)	2003-12-11	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
WO2002081692A3 (en)	2003-08-21	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048365A3 (en)	2003-05-15	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048364A3 (en)	2003-05-15	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001088136A3 (en)	2002-04-25	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002066642A3 (en)	2003-08-07	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001090360A3 (en)	2002-06-06	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002048366A3 (en)	2003-05-15	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002053740A3 (en)	2003-05-22	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002081657A3 (en)	2003-02-27	Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof